Trial Profile
An Open-Label Pilot Study Evaluating the Safety and Antidepressant Effects of Rellidep (BI= Biological Isolate) in Major Depressive Disorder
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rellidep (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 24 Mar 2014 New trial record
- 03 Dec 2013 Primary endpoint 'Hamilton-Depression-Rating-Scale' has been met.